| Eric L Zager, MD | |
|
3400 Spruce St, 3 Silverstein Bldg, Philadelphia, PA 19104 | |
| (215) 662-3487 | |
| Not Available |
| Full Name | Eric L Zager |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 42 Years |
| Location | 3400 Spruce St, Philadelphia, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124061239 | NPI | - | NPPES |
| 0011897310001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD044278E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
| Penn Presbyterian Medical Center | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Penn - Medical Group | 6204730955 | 3031 |
News Archive
Elderly patients with heart failure who see a pharmacist once a week are more likely to take their tablets and be active in daily life, according to late breaking results from the PHARM-CHF randomized controlled trial presented today at Heart Failure 2019, a scientific congress of the European Society of Cardiology.
Our environment can have a major impact on how we develop, and it turns out it's no different for cancer cells. In work published today in Neoplasia, a team of researchers led by Associate Professor Mikala Egeblad at Cold Spring Harbor Laboratory found that two different mouse models of breast cancer progressed differently based on characteristics of the tumor microenvironment - the area of tissue in which the tumor is embedded.
A new study aims to determine whether individuals with antisocial behaviors are more susceptible to COVID-19.
Targeted therapies are a growing and groundbreaking field in cancer care in which drugs or other substances are designed to interfere with genes or molecules that control the growth and survival of cancer cells. Now, scientists at Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine (VIMM) have identified a novel interaction between a microRNA and a gene that could lead to new therapies for the most common and deadly form of brain tumor, malignant glioma.
Eighty-eight percent of Medicare beneficiaries enrolled in stand-alone drug plans under the Medicare prescription drug benefit are in plans that do not provide coverage during the so-called "doughnut hole," according to a report released on Thursday by Democrats on the House Ways and Means Committee, the AP/Boston Globe reports.
› Verified 9 days ago
| Entity Name | University Of Penn - Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235527342 PECOS PAC ID: 6204730955 Enrollment ID: O20141111000091 |
News Archive
Elderly patients with heart failure who see a pharmacist once a week are more likely to take their tablets and be active in daily life, according to late breaking results from the PHARM-CHF randomized controlled trial presented today at Heart Failure 2019, a scientific congress of the European Society of Cardiology.
Our environment can have a major impact on how we develop, and it turns out it's no different for cancer cells. In work published today in Neoplasia, a team of researchers led by Associate Professor Mikala Egeblad at Cold Spring Harbor Laboratory found that two different mouse models of breast cancer progressed differently based on characteristics of the tumor microenvironment - the area of tissue in which the tumor is embedded.
A new study aims to determine whether individuals with antisocial behaviors are more susceptible to COVID-19.
Targeted therapies are a growing and groundbreaking field in cancer care in which drugs or other substances are designed to interfere with genes or molecules that control the growth and survival of cancer cells. Now, scientists at Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine (VIMM) have identified a novel interaction between a microRNA and a gene that could lead to new therapies for the most common and deadly form of brain tumor, malignant glioma.
Eighty-eight percent of Medicare beneficiaries enrolled in stand-alone drug plans under the Medicare prescription drug benefit are in plans that do not provide coverage during the so-called "doughnut hole," according to a report released on Thursday by Democrats on the House Ways and Means Committee, the AP/Boston Globe reports.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric L Zager, MD 3400 Spruce St, 3 Silverstein Bldg, Philadelphia, PA 19104-4206 Ph: () - | Eric L Zager, MD 3400 Spruce St, 3 Silverstein Bldg, Philadelphia, PA 19104 Ph: (215) 662-3487 |
News Archive
Elderly patients with heart failure who see a pharmacist once a week are more likely to take their tablets and be active in daily life, according to late breaking results from the PHARM-CHF randomized controlled trial presented today at Heart Failure 2019, a scientific congress of the European Society of Cardiology.
Our environment can have a major impact on how we develop, and it turns out it's no different for cancer cells. In work published today in Neoplasia, a team of researchers led by Associate Professor Mikala Egeblad at Cold Spring Harbor Laboratory found that two different mouse models of breast cancer progressed differently based on characteristics of the tumor microenvironment - the area of tissue in which the tumor is embedded.
A new study aims to determine whether individuals with antisocial behaviors are more susceptible to COVID-19.
Targeted therapies are a growing and groundbreaking field in cancer care in which drugs or other substances are designed to interfere with genes or molecules that control the growth and survival of cancer cells. Now, scientists at Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine (VIMM) have identified a novel interaction between a microRNA and a gene that could lead to new therapies for the most common and deadly form of brain tumor, malignant glioma.
Eighty-eight percent of Medicare beneficiaries enrolled in stand-alone drug plans under the Medicare prescription drug benefit are in plans that do not provide coverage during the so-called "doughnut hole," according to a report released on Thursday by Democrats on the House Ways and Means Committee, the AP/Boston Globe reports.
› Verified 9 days ago
Xun Li, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 800 Spruce St, Philadelphia, PA 19107 Phone: 215-316-5151 | |
Dr. Ahmet Fatih Atik, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Cotton St, Philadelphia, PA 19127 Phone: 215-892-7600 | |
Richard Schmidt, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 909 Walnut St Fl 2, Philadelphia, PA 19107 Phone: 215-955-7000 Fax: 215-503-7038 | |
Dr. Srinivasa Prasad Venkata Kanuparthi, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3401 N Broad St, Philadelphia, PA 19140 Phone: 215-707-7200 Fax: 215-707-3831 | |
John Y Lee, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce Street, 3 Silverstein Bldg, Philadelphia, PA 19104 Phone: 215-662-3487 | |
Dr. Nduka Mgbechinyere Amankulor, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3400 Civic Center Blvd, 2nd Flr South Pavilion, Philadelphia, PA 19104 Phone: 215-662-3487 Fax: 215-349-5534 | |
Kareem Amir Zaghloul, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 3400 Spruce St, 1 Maloney Building, Philadelphia, PA 19104 Phone: 215-662-3957 |